Chen Yang K, Nichols Matthew T, Antillon Mainor R
Denver, Colorado, USA.
Gastrointest Endosc. 2008 Jan;67(1):132-5. doi: 10.1016/j.gie.2007.08.024.
Patients with end-stage liver disease have an increased risk of symptomatic gallstone disease, as well as complications associated with cholecystectomy. We hypothesized that peroral transpapillary cholecystoscopy with electrohydraulic lithotripsy of gallbladder stones is technically feasible and beneficial in patients who are high operative risks.
Observational, descriptive.
Patients with Child's class C cirrhosis and with gallstone symptoms who were awaiting liver transplantation.
Gallbladder stenting, dilation of the cystic duct, cholecystoscopy, electrohydraulic lithotripsy, ursodiol therapy.
Gallbladder access and visualization, stone clearance, symptom relief, and complications.
The gallbladder wall and stones were adequately visualized. Electrohydraulic lithotripsy achieved stone clearance after two sessions. Mild postprocedure pancreatitis occurred after the first treatment. The patient remained symptom free, stent free, and stone free until a liver transplantation, which was performed 25 months later.
Proof of concept performed in a single patient.
Peroral transpapillary cholecystoscopy is technically feasible. Electrohydraulic lithotripsy of gallbladder stones under direct vision can achieve stone clearance. Patients with cirrhosis who are awaiting transplantation and other high-risk surgical candidates with symptomatic gallstone disease may benefit from this treatment option. Studies to assess the efficacy and safety of this novel technique are needed before routine clinical use can be recommended.
终末期肝病患者发生有症状胆结石疾病的风险增加,以及与胆囊切除术相关的并发症。我们推测,经口经乳头胆囊镜检查联合胆囊结石的电液压碎石术在手术风险高的患者中技术上是可行的且有益的。
观察性、描述性研究。
Child C级肝硬化且有胆结石症状并等待肝移植的患者。
胆囊支架置入、胆囊管扩张、胆囊镜检查、电液压碎石术、熊去氧胆酸治疗。
胆囊的进入和可视化、结石清除、症状缓解及并发症。
胆囊壁和结石得到充分可视化。电液压碎石术在两个疗程后实现了结石清除。首次治疗后发生了轻度术后胰腺炎。该患者在25个月后接受肝移植前一直无症状、无支架且无结石。
在单一患者中进行的概念验证。
经口经乳头胆囊镜检查在技术上是可行的。直视下胆囊结石的电液压碎石术可实现结石清除。等待移植的肝硬化患者及其他有症状胆结石疾病的高风险手术候选者可能受益于这种治疗选择。在推荐常规临床应用之前,需要进行研究以评估这种新技术的疗效和安全性。